Cargando…
Killing cancer cells by targeted drug-carrying phage nanomedicines
BACKGROUND: Systemic administration of chemotherapeutic agents, in addition to its anti-tumor benefits, results in indiscriminate drug distribution and severe toxicity. This shortcoming may be overcome by targeted drug-carrying platforms that ferry the drug to the tumor site while limiting exposure...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323368/ https://www.ncbi.nlm.nih.gov/pubmed/18387177 http://dx.doi.org/10.1186/1472-6750-8-37 |